Latest News

  • Alkermes' Corporate Presentation to be Webcast at Upcoming Healthcare Conferences Read More
  • Alkermes Presents New Data on ALKS 4230 at Society for Immunotherapy of Cancer's (SITC) 33rd Annual Meeting Read More
  • Alkermes Reports on Outcome of FDA Advisory Committee Meeting on ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder Read More

Investors

Working at Alkermes